Fungal Infections of the Nail: New Perspectives

Abstract

Get full access to this article

View all access options for this article.

References

Burzykowski G , Molenberghs G , Abeck D , et al. High prevalence of foot diseases in Europe: results of the Achilles project. Mycoses 2003;46:496-505.

Yosipovitch G , Hodak E , Vardi P , et al. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications. Diabetes Care 1998;21:506-509.

Gupta A , Konnikov N , MacDonald P , et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol 1998;139:665-671.

Dogra S , Kumar B , Bhansali A , et al. Epidemiology of onychomycosis in patients with diabetes mellitus in India. Int J Dermatol 2002;41:647-651.

Gupta AK , Gupta MA , Summerbell RC . The epidemiology of onychomycosis: possible role of smoking and peripheral arterial disease. J Eur Acad Dermatol Venereol 2000;14:466-469.

Maruyama R , Hiruma M , Yamauchi K , et al. An epidemiological and clinical study of untreated patients with tinea pedis within a company in Japan. Mycoses 2003;46:208-212.

Drake L , Scher RK , Smith EB , et al. Effect of onychomycosis on quality of life. J Am Acad Dermatol 1998;38:702-704.

Dupuy A , Benchikhi H , Roujeau JC , et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. Br Med J 1999;318:1591-1594.

Roldan Y , Mata-Essayag S , Hartung C. Erysipelas and tinea pedis. Mycoses 2000;43:181-183.

10.

Semel J , Goldin H. Association of athlete’s foot with cellulitis of the lower extremities: diagnostic value of bacterial cultures of ipsilateral interdigital space samples. Clin Infect Dis 1996;23:1162-1164.

11.

Roberts DT , Taylor WD , Boyle J. Guidelines for treatment of onychomycosis. Br J Dermatol 2003;148:402-410.

12.

Crawford F , Young P , Godfrey C , et al. Oral treatments for toenail onychomycosis: a systematic review. Arch Dermatol 2002;138:829-830.

13.

Gupta AK , Ryder J , Johnson AM . Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Br J Dermatol 2004;150:537-544.

14.

Cribier BJ , Bakshi R. Terbinafine in the treatment of onychomycosis: a review of its efficacy in high risk populations and in patients with non-dermatophyte infections. Br J Dermatol 2004;150:414-420.

15.

Sigurgeirsson B , Ólafsson JH , Steinsson J , et al. Long term effectiveness of treatment with terbinafine versus itraconazole in onychomycosis. Arch Dermatol 2002;138:353-357.

16.

Lambert J. Pharmacoeconomic issues in onychomycosis . Br J Dermatol 2003;49(Suppl 65):19-22.